Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT
Lonhala Magnair Package is a drug marketed by Sunovion Resp and is included in a single NDA. It’s accessible from one provider. There are 13 patents defending this drug.
This drug has eigthy-two patent members of the family in fifteen international locations.
The generic ingredient in LONHALA MAGNAIR KIT is glycopyrrolate. One provider is listed for this compound. Further particulars can be found on the glycopyrrolate profile web page.
For extra info on how DrugPatentWatch will help together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Make Higher Selections with DrugPatentWatch
Copyright © DrugPatentWatch. Initially revealed at New patent expiration for Sunovion Resp drug LONHALA MAGNAIR KIT
